These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 24763360

  • 1. Towards the development of 5-HT₇ ligands combining serotonin-like and arylpiperazine moieties.
    Spadoni G, Bedini A, Bartolucci S, Pala D, Mor M, Riccioni T, Borsini F, Cabri W, Celona D, Marzi M, Tarzia G, Rivara S, Minetti P.
    Eur J Med Chem; 2014 Jun 10; 80():8-35. PubMed ID: 24763360
    [Abstract] [Full Text] [Related]

  • 2. Structure-activity relationships and molecular modeling studies of novel arylpiperazinylalkyl 2-benzoxazolones and 2-benzothiazolones as 5-HT(7) and 5-HT(1A) receptor ligands.
    Salerno L, Pittalà V, Modica MN, Siracusa MA, Intagliata S, Cagnotto A, Salmona M, Kurczab R, Bojarski AJ, Romeo G.
    Eur J Med Chem; 2014 Oct 06; 85():716-26. PubMed ID: 25128671
    [Abstract] [Full Text] [Related]

  • 3. Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: synthesis and biological evaluation.
    Badarau E, Suzenet F, Bojarski AJ, Fînaru AL, Guillaumet G.
    Bioorg Med Chem Lett; 2009 Mar 15; 19(6):1600-3. PubMed ID: 19237285
    [Abstract] [Full Text] [Related]

  • 4. The impact of spacer structure on 5-HT7 and 5-HT1A receptor affinity in the group of long-chain arylpiperazine ligands.
    Bojarski AJ, Duszyńska B, Kołaczkowski M, Kowalski P, Kowalska T.
    Bioorg Med Chem Lett; 2004 Dec 06; 14(23):5863-6. PubMed ID: 15501057
    [Abstract] [Full Text] [Related]

  • 5. Solid-supported synthesis, molecular modeling, and biological activity of long-chain arylpiperazine derivatives with cyclic amino acid amide fragments as 5-HT(7) and 5-HT(1A) receptor ligands.
    Canale V, Guzik P, Kurczab R, Verdie P, Satała G, Kubica B, Pawłowski M, Martinez J, Subra G, Bojarski AJ, Zajdel P.
    Eur J Med Chem; 2014 May 06; 78():10-22. PubMed ID: 24675176
    [Abstract] [Full Text] [Related]

  • 6. Aryl biphenyl-3-ylmethylpiperazines as 5-HT7 receptor antagonists.
    Kim J, Kim Y, Tae J, Yeom M, Moon B, Huang XP, Roth BL, Lee K, Rhim H, Choo IH, Chong Y, Keum G, Nam G, Choo H.
    ChemMedChem; 2013 Nov 06; 8(11):1855-64. PubMed ID: 24039134
    [Abstract] [Full Text] [Related]

  • 7. Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR.
    Intagliata S, Modica MN, Pittalà V, Salerno L, Siracusa MA, Cagnotto A, Salmona M, Romeo G.
    Bioorg Med Chem Lett; 2016 Aug 15; 26(16):4052-6. PubMed ID: 27396505
    [Abstract] [Full Text] [Related]

  • 8. Novel 5-HT7 receptor inverse agonists. Synthesis and molecular modeling of arylpiperazine- and 1,2,3,4-tetrahydroisoquinoline-based arylsulfonamides.
    Vermeulen ES, van Smeden M, Schmidt AW, Sprouse JS, Wikström HV, Grol CJ.
    J Med Chem; 2004 Oct 21; 47(22):5451-66. PubMed ID: 15481983
    [Abstract] [Full Text] [Related]

  • 9. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ, Paluchowska MH, Duszyńska B, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E.
    Bioorg Med Chem; 2005 Mar 15; 13(6):2293-303. PubMed ID: 15727878
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.
    Handzlik J, Bojarski AJ, Satała G, Kubacka M, Sadek B, Ashoor A, Siwek A, Więcek M, Kucwaj K, Filipek B, Kieć-Kononowicz K.
    Eur J Med Chem; 2014 May 06; 78():324-39. PubMed ID: 24691057
    [Abstract] [Full Text] [Related]

  • 14. Pharmacophore Comparison and Development of Recently Discovered Long Chain Arylpiperazine and Sulfonamide Based 5-HT7 Ligands.
    Rague A, Tidgewell K.
    Mini Rev Med Chem; 2018 May 06; 18(7):552-560. PubMed ID: 28901854
    [Abstract] [Full Text] [Related]

  • 15. Towards metabolically stable 5-HT7 receptor ligands: a study on 1-arylpiperazine derivatives and related isosters.
    Lacivita E, De Giorgio P, Patarnello D, Niso M, Colabufo NA, Berardi F, Perrone R, Satala G, Duszynska B, Bojarski AJ, Leopoldo M.
    Exp Brain Res; 2013 Oct 06; 230(4):569-82. PubMed ID: 23571499
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Electrospray mass spectrometric studies of noncovalent complexes of buspirone hydrochloride and other serotonin 5-HT(1A) receptor ligands containing arylpiperazine moieties.
    Kowalski P, Suder P, Kowalska T, Silberring J, Duszyńska B, Bojarski AJ.
    Rapid Commun Mass Spectrom; 2003 Oct 06; 17(18):2139-46. PubMed ID: 12955745
    [Abstract] [Full Text] [Related]

  • 20. Structural modifications of the serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-biphenyl)-1-piperazinehexanamide (LP-211) to improve in vitro microsomal stability: A case study.
    Lacivita E, Podlewska S, Speranza L, Niso M, Satała G, Perrone R, Perrone-Capano C, Bojarski AJ, Leopoldo M.
    Eur J Med Chem; 2016 Sep 14; 120():363-79. PubMed ID: 27318552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.